Skip to main content
Clinical Trials/NCT00619320
NCT00619320CompletedPhase 2

Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women

Virginia Commonwealth University2 sites in 1 country380 target enrollmentStarted: December 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
380
Locations
2
Primary Endpoint
Number of penetrative unprotected sexual intercourse occasions

Study Overview

Brief Summary

This study will examine safer sex skills building (SSB), a targeted behavioral HIV prevention and risk reduction group intervention in two samples of pregnant drug abusing women.

Detailed Description

"Safer Sex Skills Building" in Pregnant Women: Dace Svikis, (Psychology, Ob-Gyn, Psychiatry) PI, Diane Langhorst (Social Work) and Nichole Karjane, (OB-Gyn) Co-Investigators). This study will focus on increasing Safer Sex Skills development among pregnant women at high risk for HIV infection. The "Safer Sex Skill Building" (SSB) program developed by El Bassel and Schilling (1991, 1992), has demonstrated efficacy in national studies in reducing sexual risk for HIV and other STD transmission. This manual-driven, gender-specific intervention has proven effective in reducing sexual risk behaviors in both methadone maintenance and outpatient drug-free patients. To date, however, the intervention has not been tested with pregnant drug abusing women who may actually be at increased risk if they stop using condoms or continue drug use during pregnancy. This study will examine SSB, a targeted behavioral HIV prevention and risk reduction intervention in two samples of pregnant drug abusing women. Using a 2x2 design, a randomized clinical trial will compare the five-session SSB group intervention to a one-session standard group HIV Education intervention (SE). Study findings will provide benchmark data on the efficacy of SSB for HIV and STD prevention in a diverse sample of pregnant drug abusing women.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •18 years of age and older, pregnant
  • •At prenatal care (PCC) site: screen positive for on T-ACE and TWEAK and/or drug CAGE, report drinking 3 or more drinks on at least one occasion and/or using an illicit drug at least once in the 30 days prior to pregnancy awareness, and report at least one incident of unprotected penetrative (vaginal or anal) intercourse with a male partner within the six months prior to baseline assessment.
  • •At community treatment (RBHA) site, inclusion criteria are the same except post-partum women (i.e., those who gave birth to a child 2 years of age or less) will also be eligible for study enrollment.

Exclusion Criteria

  • •Both sites:
  • •Unable to provide informed consent due to cognitive impairment, psychiatric instability, or language barriers

Arms & Interventions

Safer Sex Skill Building (SSB)

Experimental

Safer Sex Skill Building Intervention (SSB) A five session behavioral intervention focused on HIV/STD prevention and safer sex negotiation skills

Intervention: Safer Sex Skills Building (SSB) (Behavioral)

2

Active Comparator

one group session focused on standard HIV/STD education

Intervention: Safer Sex Skills Building (SSB) (Behavioral)

Outcomes

Primary Outcomes

Number of penetrative unprotected sexual intercourse occasions

Time Frame: baseline, 1 month, 3 months, and 6 months post-randomization follow-up assessment

The proportion of sex episodes involving alcohol or other drugs

Time Frame: baseline, 1 month, 3 months, and 6 months post-randomization follow-up assessment

The proportion of penetrative unprotected sex occasions (of all sex occasions)

Time Frame: baseline, 1 month, 3 months, and 6 months post-randomization follow-up assessment

Secondary Outcomes

  • Perceived self-efficacy to carry out safer sex and the carrying of condoms(baseline, 1 month, 3 months, and 6 months post-randomization follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials